Dataset Information

Enzyme Databases in the Era of Omics and Artificial Intelligence.

ABSTRACT: Enzyme research is important for the development of various scientific fields such as medicine and biotechnology. Enzyme databases facilitate this research by providing a wide range of information relevant to research planning and data analysis. Over the years, various databases that cover different aspects of enzyme biology (e.g., kinetic parameters, enzyme occurrence, and reaction mechanisms) have been developed. Most of the databases are curated manually, which improves reliability of the information; however, such curation cannot keep pace with the exponential growth in published data. Lack of data standardization is another obstacle for data extraction and analysis. Improving machine readability of databases is especially important in the light of recent advances in deep learning algorithms that require big training datasets. This review provides information regarding the current state of enzyme databases, especially in relation to the ever-increasing amount of generated research data and recent advancements in artificial intelligence algorithms. Furthermore, it describes several enzyme databases, providing the reader with necessary information for their use.

SUBMITTER: Presern U

PROVIDER: S-EPMC10707154 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Enzyme Databases in the Era of Omics and Artificial Intelligence.

Prešern Uroš U Goličnik Marko M

International journal of molecular sciences 20231129 23

Enzyme research is important for the development of various scientific fields such as medicine and biotechnology. Enzyme databases facilitate this research by providing a wide range of information relevant to research planning and data analysis. Over the years, various databases that cover different aspects of enzyme biology (e.g., kinetic parameters, enzyme occurrence, and reaction mechanisms) have been developed. Most of the databases are curated manually, which improves reliability of the inf ...[more]

PMID: 38069254

Similar Datasets

Project description:IntroductionDiscriminating asthma from chronic obstructive pulmonary disease (COPD) using medico-administrative databases is challenging but necessary for medico-economic analyses focusing on respiratory diseases. Artificial intelligence (AI) may improve dedicated algorithms.ObjectivesTo assess performance of different AI-based approaches to distinguish asthmatics from COPD patients in medico-administrative databases where the clinical diagnosis is absent. An "Asthma COPD Overlap" category was defined to further test whether AI can detect complexity.MethodsThis study included 178,962 patients treated by two "R03" treatment prescriptions at least from January 2016 to December 2018 and managed by either a general practitioner and/or a pulmonologist participating in a permanent longitudinal observatory of prescription in ambulatory medicine (LPD). Clinical diagnoses are available in this database and were used as gold standards to develop diagnostic rules. Three types of AI approaches were explored using data restricted to demographics and treatment dispensations: multinomial regression, gradient boosting and recurrent neural networks (RNN). The best performing model (based on metric properties) was then applied to estimate the size of asthma and COPD populations based on a database (LRx) of treatment dispensations between July, 2018 and June, 2019.ResultsThe best models were obtained with the boosting approach and RNN, with an overall accuracy of 68%. Performance metrics were better for asthma than COPD. Based on LRx data, the extrapolated numbers of patients treated for asthma and COPD in France were 3.7 and 1.2 million, respectively. Asthma patients were younger than COPD patients (mean, 49.9 vs. 72.1 years); COPD occurred mostly in men (68%) compared to asthma (33%).ConclusionAI can provide models with acceptable accuracy to distinguish between asthma, ACO and COPD in medico-administrative databases where the clinical diagnosis is absent. Deep learning and machine learning (RNN) had similar performances in this regard.

Project description:The integration of artificial intelligence (AI) into health communication systems has introduced a transformative approach to public health management, particularly during public health emergencies, capable of reaching billions through familiar digital channels. This paper explores the utility and implications of generalist conversational artificial intelligence (CAI) advanced AI systems trained on extensive datasets to handle a wide range of conversational tasks across various domains with human-like responsiveness. The specific focus is on the application of generalist CAI within messaging services, emphasizing its potential to enhance public health communication. We highlight the evolution and current applications of AI-driven messaging services, including their ability to provide personalized, scalable, and accessible health interventions. Specifically, we discuss the integration of large language models and generative AI in mainstream messaging platforms, which potentially outperform traditional information retrieval systems in public health contexts. We report a critical examination of the advantages of generalist CAI in delivering health information, with a case of its operationalization during the COVID-19 pandemic and propose the strategic deployment of these technologies in collaboration with public health agencies. In addition, we address significant challenges and ethical considerations, such as AI biases, misinformation, privacy concerns, and the required regulatory oversight. We envision a future with leverages generalist CAI in messaging apps, proposing a multiagent approach to enhance the reliability and specificity of health communications. We hope this commentary initiates the necessary conversations and research toward building evaluation approaches, adaptive strategies, and robust legal and technical frameworks to fully realize the benefits of AI-enhanced communications in public health, aiming to ensure equitable and effective health outcomes across diverse populations.

Dataset Information

Enzyme Databases in the Era of Omics and Artificial Intelligence.

Publications

Enzyme Databases in the Era of Omics and Artificial Intelligence.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets